Healthcare & Biotech

Bengaluru – October 07, 2026 -- Omega Healthcare has secured recognition in three separate categories of the 2026 Avtar & Seramount benchmarking studies, one of India's most rigorous assessments of workplace inclusion and wellness, with the AI-driven healthcare solutions company set to collect the awards at Avtar's Best Practices of the Best conference on Nov. 3.

Company enters Hall of Fame after sixth consecutive year on women's workplace list

Omega Healthcare was named to the Best Companies for Women in India (BCWI) list for the sixth straight year, a streak that qualifies it for entry into the BCWI Hall of Fame -- a distinction reserved for organizations ranked five or more years running. The BCWI study, now in its 11th edition, evaluates how organizations help women build careers and move into leadership.

New York – October 07, 2026 -- Elsevier has signed a strategic content agreement with the JAMA Network to integrate full-text content and visuals from 13 JAMA journals into ClinicalKey AI, its clinical-grade AI workspace, giving clinicians access to more than half of the world's top 100 medical journals through the platform.

Agreement covers 13 JAMA Network titles including flagship journal and specialty publications

The deal brings all published full-text content and visuals from JAMA, JAMA Network Open, and 11 specialty journals -- JAMA Cardiology, JAMA Dermatology, JAMA Health Forum, JAMA Internal Medicine, JAMA Neurology, JAMA Oncology, JAMA Ophthalmology, JAMA Otolaryngology-Head & Neck Surgery, JAMA Pediatrics, JAMA Psychiatry and JAMA Surgery -- into the responses clinicians receive through ClinicalKey AI. Content is available to ClinicalKey AI customers immediately.

Goleta, Calif. – October 7, 2026 -- Vitamin Angels presented new implementation research at the 2026 Micronutrient Forum Global Conference in Accra, Ghana, revealing a sharp gap between access to maternal nutrition supplements and actual completion of recommended courses. In Makueni County, Kenya, formative research found that while 93% of pregnant women surveyed received iron and folic acid supplementation, only 17% completed the recommended 180-day course, even as 95% of pregnant women and 96% of health providers backed multiple micronutrient supplementation (MMS).

London – – October 07, 2026 -- The global cold plasma in healthcare market is projected to climb from $2,873 million in 2025 to $6,634 million by 2032, a compound annual growth rate of 12.7%, according to a new report from Credence Research Inc.

Devices dominate revenue while consumables build recurring streams

Devices accounted for 68.4% of product-segment revenue in 2025, reflecting continued emphasis on installed treatment capacity ahead of scaling consumables and service income. Plasma Jet technology held 39.6% of the technology segment, while Atmospheric Pressure Cold Plasma captured 66.8% of the pressure-type category, favored for bedside and outpatient use without vacuum infrastructure.

Irvine, Calif. – October 07, 2026 -- MAXAIR Systems will supply a substantial quantity of its CAPR® helmet systems and related disposable equipment to World Vision for Ebola response efforts in the Democratic Republic of the Congo.

MAXAIR deepens 25-year partnership with World Vision on frontline protective gear

The Irvine, Calif.-based respiratory protection manufacturer confirmed the contribution is intended for healthcare professionals, humanitarian workers and other frontline teams operating in communities affected by the outbreak in the Democratic Republic of the Congo.

Rockville, Md. – October 07, 2026 -- The Agency for Healthcare Research and Quality (AHRQ) has launched a two-part, $7.95 million prize competition designed to compress medical evidence reviews that currently take a year or more down to a matter of hours using super intelligence systems.

Grand prize of $5.35 million targets evidence synthesis, the largest SI award issued to date

The Clinical Evidence Synthesis Transformation Challenge carries a $5.35 million grand prize, which AHRQ describes as the largest individual super intelligence grand prize awarded to date. Entrants will be judged on accuracy, throughput, reproducibility, usability and ease of operation. AHRQ Director Roger D. Klein, M.D., J.D., said the technology now allows evidence synthesis to be performed with speed, consistency and reproducibility that was previously unimaginable, a shift he said will help doctors, patients, payers and policymakers avoid unnecessary or harmful care.

Dallas – October 07, 2026 -- Patients who completed Annual Wellness Visits through Primary Partners Alliance's (PPA) population health strategy generated nearly $70 lower per-member-per-month healthcare costs than those who did not, according to a one-year analysis of the organization's Medicare Shared Savings Program and ACO REACH population.

AWV completion drove measurable cost and utilization reductions across PPA's network

The analysis found per-member-per-month costs of $947 for patients who completed an AWV versus $1,014 for those who did not. Readmission rates were 44% lower among AWV completers, at 9% compared with 16% for non-completers. Emergency department utilization also fell, registering 272 visits per 1,000 patients versus 286 per 1,000 for the comparison group.

New York – October 07, 2026 -- Castle Connolly, which has vetted top U.S. healthcare providers for more than 35 years, has partnered with reputation management firm rater8 to deploy automated patient review tools across its national network of Top Doctors, Top Dentists, and Top Hospitals.

Partnership pairs peer-nominated rankings with automated patient feedback collection

Under the deal, Castle Connolly will offer rater8's Visibility Engine (raVE) platform to hospitals, group practices, doctors, and dentists nationwide. The combined offering merges Castle Connolly's independent, peer-nominated provider recognition with rater8's automated system for capturing post-visit patient sentiment and generating online reviews.

Stockholm – October 07, 2026 -- SciBase Holding AB has recalculated the terms of its series TO 2 warrants following a rights issue of shares resolved by its board on September 3, 2026, cutting the subscription ratio to 0.01 shares per warrant.

Subscription price drops to SEK 37.47 per share under new warrant terms

Each TO 2 warrant now entitles the holder to subscribe for 0.01 new shares at SEK 37.47 per share, down from the original terms set when the instrument was issued alongside SciBase's April 2024 capital raise. The adjustment follows contractual provisions requiring recalculation of warrant terms whenever the company conducts a subsequent rights issue.

Stockholm – October 07, 2026 -- SciBase Holding AB has resolved on a set-off share issue of 60,000 new shares to Bergs Securities AB, settling part of the guarantee compensation owed for underwriting the company's recently completed rights issue.

Board approves compensation shares at SEK 15 apiece

The Board of Directors resolved on the Compensation Issue on October 7, 2026, under authorization granted at the Annual General Meeting on May 19, 2026. The subscription price of SEK 15 per share matches the price set in the underlying rights issue. Payment was made entirely through set-off against SEK 0.9 million of Bergs Securities' claim for guarantee compensation, and all 60,000 shares have been subscribed for and allotted.